tirzepatide for heart failure with preserved ejection fraction and obesity Reduced Fraction: A Review ESC 2025: study supports use

But depending on the individual, the most powerful reason might be cosmetic. The soaring demand for GLP-1s has created shortages across the country

An overview of once-weekly glucagon-like peptide-1 receptor agonistsavailable efficacy and safety data and perspectives for the future

PlexusDx compounded semaglutide and tirzepatide medications meet IRS criteria for HSA and FSA eligible expenses because they treat a diagnosed medical condition under a healthcare provider's supervision

Our aloha-inspired clinics on Oahu, Hawaii Island, and Maui make physician-supervised weight loss accessible across Hawaii

In-person & telehealth In-person & telehealth In-person & telehealth